Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Laurus Labs, Unitaid and the Clinton Health Access Initiative, announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children

Posted On: 2021-09-14 08:07:56 (Time Zone: UTC)


Laurus Labs Limited ( BSE: 540222, NSE: LAURUSLABS, ISIN: INE947Q01028), a leading research & development-driven and fully integrated pharmaceutical and biotech company in India ("the Company"), announces that the development is underway based on an agreement launched in June 2021 the Company, Unitaid and the Clinton Health Access Initiative (CHAI), to accelerate the development, commercialization, and registration of the bestin-class second- and third-line HIV treatment darunavir boosted with ritonavir (DRV/r) for children. Despite being available in high-income countries for over a 15-year period, a generic, fixed-dose combination pediatric version of DRV/r is still not available. Through this agreement, Unitaid and CHAI are working with the Company to finally address this critical need and ensure CLHIV (Children Living with HIV/AIDS) have access to high-quality second- and third-line HIV treatment.

Unitaid Executive Director Dr. Philippe Duneton said, "Enabling children and young people to have access to the best possible HIV treatment is a key priority for Unitaid - whether that's first, second, or third-line treatment. This agreement is a welcome step towards having a long-awaited pediatric formulation of DRV/r available, as we strive to achieve the global goal of 90% of people living with HIV receiving antiretroviral therapy."

Second and third-line therapies are critical for CLHIV where the World Health Organization (WHO)-recommended first-line treatment dolutegravir (DTG) may not be an option due to medication resistance or intolerance. Currently available secondand third-line treatments are often difficult for children to take due to bitter taste and difficult forms of administration.

"A pediatric version of DRV/r has been a global health priority since 2013, but is still not available, leaving thousands of children without the lifesaving medication they need," said Ann Veneman, interim Co-CEO of CHAI. "The innovative incentive program announced today will enable development of an effective pediatric medication that will save the lives of children living with HIV."

The product development collaboration between Unitaid, CHAI, and Laurus Labs was spearheaded through Unitaid's investment in CHAI since 2016 to bring the best HIV medications to market more quickly and integrate them into treatment programs in low- and middle-income countries that need them the most.

Understanding the small market size for a pediatric version of DRV/r, the initiative has provided Laurus with a financial incentive for a portion of their development and commercialization costs. CHAI will work closely with Laurus Labs to provide technical and regulatory support to enable accelerated generic development and regulatory submission of the medication. Commenting on the collaboration in development of the new second line and third line pediatric treatment, Dr. Satyanarayana Chava, Founder & CEO, Laurus Labs, said, "we are excited about this innovative mechanism to accelerate the availability of pDRV/r regimen for children living with HIV.

The collaboration between Laurus Labs, CHAI, and Unitaid can positively impact over 100,000 CLHIVs and help them in leading a better life especially in their formative years."

Shares of Laurus Labs Limited was last trading in BSE at Rs. 645.9 as compared to the previous close of Rs. 656. The total number of shares traded during the day was 67056 in over 2693 trades.

The stock hit an intraday high of Rs. 654.8 and intraday low of 644.9. The net turnover during the day was Rs. 43551926.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

KPI Global Infrastructure Ltd commissions solar power plant under CPP

Religare Broking Ltd. introduces new features for IPO application

American Airlines and IndiGo announce Codeshare Agreement

mjunction organises meet on digitisation in steel sales

Apollo Hospitals - No.1 Indian Heart Hospital as per latest Newsweek survey

Muthoot Finance launches AI Virtual Assistant 'Mattu'

TCS Partners with Newgen for their Flagship Banking Service Bureau Project in Israel

Shreyas Shipping and Logistics Ltd to acquire bulk carrier

Orbit Exports Limited completes new project

MTAR Technologies Limited receives accolade for Indigenous Ball Screws

Interactive Financial Services Ltd receives SEBI approval as a registered merchant banker

Ganesh Benzoplast Ltd to consider job work agreement with GBL Chemical Ltd

ATUL Auto Ltd commences commercial production at Bhayla plant

HCL Technologies Joins AWS Service Delivery Program, Becomes AWS Contact Center Intelligence Partner

NBCC India Ltd and DTC update on development of land parcels

IMP Powers Limited submits resolution plan for restructuring credit facilities

Lupin Launches Droxidopa Capsules in the United States

Compucom Software Limited receives LOA for Rs. 6.07 crores order

Allcargo Belgium NV to evaluate fund raising opportunities for PE and strategic investment

New Release of TCS MasterCraft™ TransformPlus 5.0 Uses ML to Enhance Legacy Application Modernization

Gallantt Metal Ltd approves sale of 106 acres land in Halavarthi, Koppal district

SRF Limited fixes Oct 14, 2021 as recrod date for bonus issue

Gallantt Ispat Ltd to invest Rs. 135 crores in Gallantt Industry Pvt Ltd

CARE reaffirms credit rating of Ruchi Infrastructure Ltd

Morgan Ventures Ltd announces resignation of Director

Wipro Ltd board to consider Q2, H1FY22 results on Oct 12-13, 2021

Bharti Airtel Limited long-term rating upgraded to 'CRISIL AA+/Stable', short-term rating reaffirmed

Infosys and SAP Collaborate to Drive Business Innovation with New Leads and Proposals Solution for the Professional Services Industry

Raghuvir Synthetics Ltd board fixes Oct 29, 2021 as record date for stock split

Star Housing Finance Ltd crosses AUM of Rs. 100 crores

DJ Mediaprint & Logistics Limited empanelled by LIC of India, Divisional Office, Machilipatnam

Rail Vikas Nigam Ltd secures Indore Metro Rail contract for Rs. 381.95 crore

Shivalik Rasayan Ltd submits another CEP to EDQM, Europe

Tata Tele Business Services launches 'EZ Cloud Connect' for Businesses

Gujarat Gas Ltd gets favorable verdict from Supreme Court

BHEL awarded order for Upgraded Main Gun of Frontline Ships

Bal Pharma poised to strengthen its position in diabetes segment through its API Gliclazide

Unison Metals Ltd fixes Record Date for Bonus Issue

NORD/LB Selects TCS as Strategic Partner for its IT Transformation

IndusInd Bank Ltd completes sale of balance shares of McLeod Russel India Ltd

Sun Pharma launches Chericof® 12 in India, a novel formulation that provides relief from cough for up to 12 hours

LTI and eClinicalHealth form strategic partnership to accelerate Innovation in Clinical Research

Sharika Enterprises Ltd receives order for Rs. 67.73 lakhs

White Organic Retail Ltd gearing up for synergy with 'Suumaya Group'

Anupam Rasayan signs LOI worth Rs 145 Cr with European Multinational Company

Quick Heal appoints global industry veteran Richard Stiennon to its Board

RBI imposes penalty of Rs. 2 crore on RBL Bank Ltd

Whirlpool India enters into agreements to acquire majority stake of Elica PB India

Indiabulls Housing Finance Ltd. raises ₹ 27 crores by selling part of its stake in OakNorth Holdings Ltd

Federal Bank launches RuPay Signet Contactless Credit Card


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020